| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival
|
Ugurel, S.
|
|
|
26 |
3 |
p. 573-582
|
artikel
|
| 2 |
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
|
Santoro, A.
|
|
|
26 |
3 |
p. 542-547
|
artikel
|
| 3 |
A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer
|
Jimeno, A.
|
|
|
26 |
3 |
p. 556-561
|
artikel
|
| 4 |
A review of the management of elderly patients with non-small-cell lung cancer
|
Blanco, R.
|
|
|
26 |
3 |
p. 451-463
|
artikel
|
| 5 |
Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers
|
Li, J.
|
|
|
26 |
3 |
p. 517-522
|
artikel
|
| 6 |
Continuous versus intermittent chemotherapy strategies in metastatic colorectal cancer: a systematic review and meta-analysis
|
Berry, S.R.
|
|
|
26 |
3 |
p. 477-485
|
artikel
|
| 7 |
EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
|
Hong, J.Y.
|
|
|
26 |
3 |
p. 548-555
|
artikel
|
| 8 |
Editorial board
|
|
|
|
26 |
3 |
p. ii-iii
|
artikel
|
| 9 |
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study
|
Schöffski, P.
|
|
|
26 |
3 |
p. 598-607
|
artikel
|
| 10 |
Evaluating surrogacy metrics and investigating approval decisions of progression-free survival (PFS) in metastatic renal cell cancer: a systematic review
|
Johnson, K.R.
|
|
|
26 |
3 |
p. 485-496
|
artikel
|
| 11 |
Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients
|
Mostert, B.
|
|
|
26 |
3 |
p. 510-516
|
artikel
|
| 12 |
Impact of centralization on aCGH-based genomic profiles for precision medicine in oncology
|
Commo, F.
|
|
|
26 |
3 |
p. 582-588
|
artikel
|
| 13 |
Nit-Picking around second line inEGFRwt NSCLC: just an academic effort
|
Landi, L.
|
|
|
26 |
3 |
p. 448-450
|
artikel
|
| 14 |
Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey †
|
Belkacemi, Y.
|
|
|
26 |
3 |
p. 529-535
|
artikel
|
| 15 |
Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer
|
Wang, C.
|
|
|
26 |
3 |
p. 523-528
|
artikel
|
| 16 |
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—a long-term follow-up study
|
Kasenda, B.
|
|
|
26 |
3 |
p. 608-611
|
artikel
|
| 17 |
Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer
|
Scagliotti, G.V.
|
|
|
26 |
3 |
p. 497-504
|
artikel
|
| 18 |
Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA–N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy †
|
Li, N.
|
|
|
26 |
3 |
p. 504-509
|
artikel
|
| 19 |
Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer
|
Sotelo, M.J.
|
|
|
26 |
3 |
p. 535-541
|
artikel
|
| 20 |
Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysis
|
Petridou, E.T.
|
|
|
26 |
3 |
p. 589-597
|
artikel
|
| 21 |
Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)
|
Ferrari, A.
|
|
|
26 |
3 |
p. 567-572
|
artikel
|
| 22 |
Table of Contents
|
|
|
|
26 |
3 |
p. iv-v
|
artikel
|
| 23 |
TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO) †
|
Grünwald, V.
|
|
|
26 |
3 |
p. 561-567
|
artikel
|
| 24 |
The failure of figitumumab: the danger of taking shortcuts in drug development
|
West, H.
|
|
|
26 |
3 |
p. 447-448
|
artikel
|
| 25 |
Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013
|
Papamichael, D.
|
|
|
26 |
3 |
p. 463-476
|
artikel
|
Tijdschrift beschrijving